DGXQuest Diagnostics Incorporated

DGX Stock Price, Valuation & Chart | Quest Diagnostics Incorporated

Compare

$240.80+4.58 (+1.94%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Diagnostics & Research DGX intrinsic value DGX calculated fair value vs price

Overview Financials Dividends Ratios

DGX Historical price chart

DGX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization26.58B

PE Ratio23.75

EPS10.14

Trading Volume1.14M

Today's High/Low242.84/236.27

Dividend Yield1.38

52 Week High/Low247.19/171.18

Shares Outstanding110.37M

DGX Financial Statement

DGX Analyst ratings

DGX Analysis & performance metrics

DGX Company profile

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic…

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily…

DGX Management team

Name

Position

Sam A. SamadCFO

Executive Vice President & Chief Financial Officer

Karthik Kuppusamy Ph.D.

Senior Vice President of Clinical Solutions

Michael J. Deppe

Senior Vice President, Corporate Controller & Chief Accounting Officer

Murali BalakumarCTO

Senior Vice President and Chief Information & Digital Officer

Shawn C. Bevec

Vice President of Investor Relations

James E. DavisCEO

Chairman, Chief Executive Officer & President

Catherine T. Doherty

Executive Vice President of Regional Businesses

Michael E. Prevoznik J.D.

Senior Vice President & General Counsel

Name

Position

Sam A. SamadCFO

Executive Vice President & Chief Financial Officer

Karthik Kuppusamy Ph.D.

Senior Vice President of Clinical Solutions

Michael J. Deppe

Senior Vice President, Corporate Controller & Chief Accounting Officer

Murali BalakumarCTO

Senior Vice President and Chief Information & Digital Officer

Shawn C. Bevec

Vice President of Investor Relations

James E. DavisCEO

Chairman, Chief Executive Officer & President

Catherine T. Doherty

Executive Vice President of Regional Businesses

Michael E. Prevoznik J.D.

Senior Vice President & General Counsel

Management Team

Sam A. SamadCFO

Executive Vice President & Chief Financial Officer

Karthik Kuppusamy Ph.D.

Senior Vice President of Clinical Solutions

Michael J. Deppe

Senior Vice President, Corporate Controller & Chief Accounting Officer

Murali BalakumarCTO

Senior Vice President and Chief Information & Digital Officer

Shawn C. Bevec

Vice President of Investor Relations

James E. DavisCEO

Chairman, Chief Executive Officer & President

Catherine T. Doherty

Executive Vice President of Regional Businesses

Michael E. Prevoznik J.D.

Senior Vice President & General Counsel

Management

Sam A. SamadCFO

Executive Vice President & Chief Financial Officer

Karthik Kuppusamy Ph.D.

Senior Vice President of Clinical Solutions

Michael J. Deppe

Senior Vice President, Corporate Controller & Chief Accounting Officer

Murali BalakumarCTO

Senior Vice President and Chief Information & Digital Officer

Shawn C. Bevec

Vice President of Investor Relations

James E. DavisCEO

Chairman, Chief Executive Officer & President

Catherine T. Doherty

Executive Vice President of Regional Businesses

Michael E. Prevoznik J.D.

Senior Vice President & General Counsel

Total 8 executives

DGX Frequently asked questions

What is Quest Diagnostics Incorporated (DGX) Stock Price?

Current stock price of Quest Diagnostics Incorporated (DGX) stock is $240.80. The stock price is +1.94% higher in the session. The intraday range can be seen from this page. Volume of Quest Diagnostics Incorporated (DGX) stock is 1.14M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Quest Diagnostics Incorporated (DGX) stock price going up or down today?

The stock price of Quest Diagnostics Incorporated (DGX) can change with earnings, company news, and overall market sentiment. Quest Diagnostics Incorporated operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Quest Diagnostics Incorporated stock expensive at its current price?

Whether Quest Diagnostics Incorporated looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for DGX on this page is 23.75. EPS on this page is 10.14. Compare those figures with peers and growth expectations before deciding if the current Quest Diagnostics Incorporated price is justified.

How has the stock price of Quest Diagnostics Incorporated (DGX) performed historically?

Historical performance for Quest Diagnostics Incorporated (DGX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how DGX reacted to past earnings and market events.

Should I buy Quest Diagnostics Incorporated (DGX) stock, at this price?

Buying Quest Diagnostics Incorporated (DGX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.